Emmaus Life Sciences, Inc. (EMMA): EPS (Basic)
-$0.12
Year ended 2025-12-31
| Period ended | EPS (Basic) | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$0.12 | n/m | 2026-03-31, From 2025-01-01 |
| 2024-12-31 | -$0.10 | n/m | 2026-03-31, From 2024-01-01 |
| 2023-12-31 | -$0.07 | n/m | 2025-04-14, From 2023-01-01 |
| 2022-12-31 | -$0.21 | n/m | 2024-07-03, From 2022-01-01 |
| 2021-12-31 | -$0.32 | n/a | 2023-03-31, From 2021-01-01 |
| No annual figure between 2013-09-30 and 2021-12-31. | |||
| 2013-09-30 | -$0.14 | n/m | 2013-12-23, From 2012-10-01 |
| 2012-09-30 | -$1.81 | n/m | 2013-12-23, From 2011-10-01 |
| 2011-09-30 | -$4.74 | n/c | 2013-01-15, From 2010-10-01 |
| 2010-09-30 | -$0.16 | n/a | 2011-12-22, From 2009-10-01 |
EPS (Basic) at similar companies
| Company | Year ended | EPS (Basic) | Change YoY |
|---|---|---|---|
| Emmaus Life Sciences, Inc. (EMMA) | 2025-12-31 | -$0.12 | n/m |
| Prelude Therapeutics Inc (PRLD) | 2025-12-31 | -$1.29 | n/m |
| Evommune, Inc. (EVMN) | 2025-12-31 | -$11.22 | n/m |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 2025-12-31 | -$14.57 | n/m |
| Jaguar Health, Inc. (JAGX) | 2025-12-31 | -$22.97 | n/m |
| CV Sciences, Inc. (CVSI) | 2025-12-31 | -$0.01 | n/m |
| Pyxis Oncology, Inc. (PYXS) | 2025-12-31 | -$1.28 | n/m |
| Arbutus Biopharma Corp (ABUS) | 2025-12-31 | -$0.17 | n/m |
| Opus Genetics, Inc. (IRD) | 2025-12-31 | -$0.80 | n/m |
Compare EMMA, PRLD, EVMN, TNXP side by side · Screen every company in Pharmaceutical Preparations ↗